Nonmicrobial Activation of TLRs Controls Intestinal Growth, Wound Repair, and Radioprotection

por Stenson, William F., Ciorba, Matthew A.
Publicado 2021

Butyrate and Mucosal Inflammation: New Scientific Evidence Supports Clinical Observation

por Cushing, Kelly, Alvarado, David M, Ciorba, Matthew A
Publicado 2015

Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach

por Christophi, George P, Rengarajan, Arvind, Ciorba, Matthew A
Publicado 2016

Corrigendum to: Assessment of Benefit of Advanced Inflammatory Bowel Disease Training: Challenges and Solutions

por Cushing, Kelly C, Adar, Tomer, Ciorba, Matthew, Ananthakrishnan, Ashwin N
Publicado 2021

Assessment of Benefit of Advanced Inflammatory Bowel Disease Training: Challenges and Solutions

por Cushing, Kelly C, Adar, Tomer, Ciorba, Matthew, Ananthakrishnan, Ashwin N
Publicado 2020

Adding Fuel to the Fire? A Role of Intraepithelial Lymphocytes in Enteric Immune Responses to SARS-CoV-2 Infection

por Antia, Avan, Alvarado, David M., Ding, Siyuan, Ciorba, Matthew A.
Publicado 2022

WITHDRAWN: Adding Fuel to The Fire? A Role of Intraepithelial Lymphocytes in Enteric Immune Responses to SARS-CoV-2 Infection

por Antia, Avan, Alvarado, David M., Ding, Siyuan, Ciorba, Matthew A.
Publicado 2021

Tu1110: EXPRESSION OF EPITHELIAL PROTEASES PREDICTS SARS-COV-2 ENTRY IN HUMAN ENTEROIDS

por Alvarado, David M., Son, Juhee, Sonnek, Naomi, Ding, Siyuan, Ciorba, Matthew A.
Publicado 2022

IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype

por Lee, Alexander, Kanuri, Navya, Zhang, Yuanhao, Sayuk, Gregory S., Li, Ellen, Ciorba, Matthew A.
Publicado 2014

Correction: IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype

por Lee, Alexander, Kanuri, Navya, Zhang, Yuanhao, Sayuk, Gregory S., Li, Ellen, Ciorba, Matthew A.
Publicado 2015

INCREASED CATHEPSIN EXPRESSION CORRELATES WITH SARS-COV-2 INFECTION IN HUMAN IBD ENTEROIDS

por Alvarado, David, Castro, Maria Gomez, Sonnek, Naomi, Cui, Xueyang, Ding, Siyuan, Ciorba, Matthew
Publicado 2021

Su102 DIFFERENCES IN INTESTINAL EPITHELIAL GENE EXPRESSION MODULATES SARS-COV-2 INFECTION IN HUMAN IBD ENTEROIDS

por Alvarado, David M., Castro, Maria Gomez, Sonnek, Naomi, Cui, Xueyang, Ding, Siyuan, Ciorba, Matthew A.
Publicado 2021

Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.

por Alvarado, David M., Son, Juhee, Thackray, Larissa B., Diamond, Michael S., Ding, Siyuan, Ciorba, Matthew A.
Publicado 2021

Nonalcoholic Fatty Liver Disease Is a Risk Factor for Thiopurine Hepatotoxicity in Crohn’s Disease

por George, Alvin T, Glover, Matthew, Alayo, Quazim, Zulfiqar, Maria, Ludwig, Daniel R, Ciorba, Matthew A, McHenry, Scott, Deepak, Parakkal
Publicado 2023

Self-reported sleep disturbance in Crohn’s disease is not confirmed by objective sleep measures

por Iskandar, Heba N., Linan, Emily E., Patel, Ami, Moore, Renee, Lasanajak, Yi, Gyawali, C. Prakash, Sayuk, Gregory S., Ciorba, Matthew A.
Publicado 2020

Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions

por Sheikh, Alaullah, Rashu, Rasheduzzaman, Begum, Yasmin Ara, Kuhlman, F. Matthew, Ciorba, Matthew A., Hultgren, Scott J., Qadri, Firdausi, Fleckenstein, James M.
Publicado 2017

Current and Prospective Methods for Assessing Anti-Tumor Immunity in Colorectal Cancer

por Nussbaum, Yulia I., Manjunath, Yariswamy, Suvilesh, Kanve N., Warren, Wesley C., Shyu, Chi-Ren, Kaifi, Jussuf T., Ciorba, Matthew A., Mitchem, Jonathan B.
Publicado 2021

Corticosteroids Increase the Risk of Invasive Fungal Infections More Than Tumor Necrosis Factor-Alpha Inhibitors in Patients With Inflammatory Bowel Disease

por Gregory, Martin H, Spec, Andrej, Stwalley, Dustin, Gremida, Anas, Mejia-Chew, Carlos, Nickel, Katelin B, Ciorba, Matthew A, Rood, Richard P, Olsen, Margaret A, Deepak, Parakkal
Publicado 2023

Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner

por Ciorba, Matthew A, Riehl, Terrence E, Rao, M Suprada, Moon, Clara, Ee, Xueping, Nava, Gerardo M, Walker, Monica R, Marinshaw, Jeffrey M, Stappenbeck, Thaddeus S, Stenson, William F
Publicado 2011

Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program

por Lichtenstein, Gary R, Rogler, Gerhard, Ciorba, Matthew A, Su, Chinyu, Chan, Gary, Pedersen, Ronald D, Lawendy, Nervin, Quirk, Daniel, Nduaka, Chudy I, Thorpe, Andrew J, Panés, Julian
Publicado 2020